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1. Introduction 
The rate of glucose consumption by ascites tumour 
cells following the addition of glucose to cells incu- 
bated in vitro is subject to rapidly acting control 
mechanisms. There is evidence for an important regu- 
latory site at hexokinase. Three phases have been dis- 
tinguished: (1) an initially rapid rate of glucose up- 
take and phosphorylation with apparently maximal 
hexokinase activity; (2) a marked inhibition of hexo- 
kinase; (3) a slow steady rate which is only lo-20% of 
the initial rate [ 141. While the concentrations of cer- 
tain glycolytic intermediates during these different 
phases are known [l-4], relatively little is known 
about the concentration changes of intermediates of 
the pentose phosphate pathway under these varied 
rates of glucose&phosphate formation. Measure- 
ments have therefore been made of the concentra- 
tions of glucose&phosphate (G6-P), 6-phosphogluco- 
nate, the pentose phosphates, sedoheptulose 7-phos- 
phate, erythrose 4-phosphate, glyceraldehyde 3-phos- 
phate and ATP during the transient initial stage and 
the later steady state conditions of glucose metabo- 
lism. It was found that while 6-phosphogluconate, the 
pentose phosphates and triose phosphate changed in 
parallel with alterations in G6P, the concentration of 
both sedoheptulose 7-phosphate and erythrose 4- 
phosphate behaved differently. Sedoheptulose 7- 
phosphate, in particular, was sustained at a high and 
relatively constant concentration and showed a ten- 
dency to be inversely related to the G6P concentra- 
tion. These results are discussed in relation to the con- 
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trol of the pentose phosphate pathway of glucose me- 
tabolism. 
2. Materials and methods 
The substrates and purified enzymes used in the 
assay of the metabolites were all purchased from 
Boehringer and Soehne, Mannheim, Germany, with 
the following exceptions: transaldolase was a gift 
from Dr. B.L.Horecker; spleen enzymes (a mixture of 
ribulose S-phosphate epimerase and ribose 5-phos- 
phate isomerase) were prepared by the method of 
Ashwell and Hickman [5] ; transketolase was prepared 
by the method of Simpson [6] as modified by Novel- 
lo and McLean [7] but the purification was stopped 
short of the treatment with lead acerate. Transketo- 
lase prepared by the above procedure was free from 
enzymes oxidising NADH but was contaminated with 
aldolase. 
Krebs 2 ascites tumour cells were harvested 7 days 
after implantation, and were then washed free from 
ascites plasma and red blood cells by differential cen- 
trifugation in 0.154 M-NaCl with heparin (1 unit/ml) 
and their packed weight determined. The cells were 
suspended in Krebs-Ringer phosphate buffer, without 
calcium, the final suspension contained 1 g cells/S ml. 
After withdrawal of a zero time sample, glucose was 
added to make a final concentration of 10 mM and 
the cells were incubated at 370 in a large beaker with ’ 
shaking at a rate of 90 cycles/min. Subsequent sam- 
ples were withdrawn at the stated time intervals, de- 
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proteinised with ice cold perchioric acid and neutral- 
ised with KOH. The supernatant after removal of po- 
tassium perchlorate was diluted to make the final ex- 
tract equivalent to 1 g cells/l0 ml. 
Metabolites were estimated by standard methods 
described by Bergmeyer [8]. Sedoheptulose 7-phos- 
phate and erythrose 4-phosphate were estimated using 
transaldolase as described by Racker [9]. Dihydroxy- 
acetone phosphate, glyceraldehyde 3-phosphate, fruc- 
ose 1 : 6 diphosphate and pentose phosphates were 
estimated in the same cuvette by the sequential addi- 
tion of ol-glycerophosphate dehydrogenase, triose iso- 
merase, aldolase, spleen enzymes and transketolase and 
by following the oxidation of NADH. 
All results are expressed as pmoles substrate/g 
packed cells. 
3. Results and discussion 
The results are summarized in fig. 1, the upper part 
GLUCOSE B-PHOSPHATE 
0.25- 
TIME IN MINUTES 
Fig. 1. Concentration of intermediates of the pentose phosphate pathway in Krebs ascites cells metabolising glucose. The incuba- 
tion procedures and assay of metaboiites were as described in the Methods. The initial glucose concentration was 10 mM, the glu- 
cose was added after withdrawal of the zero time sample. The results are given as bmoles substrate/g packed cells. 
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of which shows the concentration changes of G6-P, 6- 
phosphogluconate and the combined values for the 
pentose phosphates (the sum of ribose 5-phosphate, 
ribulose 5phosphate and xylulose 5-phosphate). The 
pattern of change of these metabolites is very similar, 
an initial rise over the first minute being followed by 
a short period of inhibition and then by a slow in- 
crease to the steady state levels. The G6-P concentra- 
tion changes are similar to those reported by Sauer 
[l] for Ehrlich-Lettre ascites cells. During the first 30 
set after the addition of glucose there is some 25fold 
increase in the G6-P concentration. This is followed 
by a period of inhibition and then, at S-10 min, by a 
slow increase in the G6-P concentration at about 5% 
of the apparent initial rate. It has been shown that 
the ATP/G6-P concentration is a key factor in the 
control of hexokinase [ 1,2,4]. A 90-95s inhibition 
of hexokinase was found when the ratio ATP/G6-P 
approached 3 at 1 mM-ATP concentration and with 
3 mM-Pi [ 11. In the present experiments this quotient 
was over 200 before the addition of glucose to the 
cells (1.7/0.008 @moles/g cells respectively) and fell 
to a value of 5,30 set after glucose was added. The 
steady state quotient ATP/G6-P after a 30 min period 
of incubation was 5 (1.25/0.25 pmoles/g cells respec- 
tively). A very marked inhibition of G6-P formation 
l-2 min after addition of glucose may be due to fac- 
tors other than the ATP/G6-P quotient since this val- 
ue was not markedly different from that found at 30 
set and in the steady state at 30 min. The quotient 
ATP/G6-P was approximately 4 at both 1 and 2 min 
(0.87/0.21 and 0.65/0.16 respectively). More signifi- 
cant may be the ratio and the absolute values of ATP/ 
ADP. It is known that ADP is a competitive inhibitor 
of brain, skeletal muscle and heart hexokinase and 
that the Kl is similar to the Km for ATP that is 
1.3 X 104 M [lo]. At 1 and 2 min after addition of 
glucose the ADP concentration in the ascites tumour 
cells reached a maximum value and the quotient ATP/ 
ADP fell to less than 1; the values as gmoles/g cells 
are 0.87/l .03 and 0.65/0.71 respectively. This quo- 
tient contrasts with all the other values found in the 
present experiments which are all greater than 1 and 
which reach a value of approximately 3.5 during the 
steady state period 30 mm after addition of glucose. 
The changes in sedoheptulose 7-phosphate are 
quite dissimilar from those of G6P and 6-phosphoglu- 
conate (fig. 1). There is initially a relatively high con- 
centration of sedoheptulose 7-phosphate in the ab- 
sence of glucose which decreases 1 mm after the addi- 
tion of glucose to the medium and thereafter shows a 
slow decline; that is, a change tending in the opposite 
direction from that of G6-P. The concentration 
changes of glyceraldehyde 3-phosphate show that 
there is a rise in the concentration of the triose phos- 
phates at a time when sedoheptulose 7-phosphate de- 
creases and this may be correlated with the require- 
ment for glyceraldehyde 3-phosphate in the further 
metabolism of sedoheptulose 7-phosphate by the 
transaldolase reaction. It may be postulated that at 
low glyceraldehyde 3-phosphate concentrations, such 
as exist in the basal state before the addition of glu- 
cose, the sedoheptulose 7-phosphate cannot be me- 
tabolised further by the transaldolase reaction. As the 
concentration of glyceraldehyde 3-phosphate rises 
with the flow of glucose through the glycolytic path- 
way, so sedoheptulose 7-phosphate is utilised by the 
transaldolase reaction. This is supported by the late 
rise found in the concentration of eythrose 4-phos- 
phate which reaches a maximum value 5 min after ad- 
dition of glucose (fig. 1). 
Horecker et al. [ 1 l] first drew attention to the im- 
portance of competing reactions for triose phosphate 
in controlling the products when liver preparations 
were incubated with ribose 5-phosphate in vitro. The 
draining of triose phosphate by the formation of fruc- 
tose 1 : 6 diphosphate and fructose 6-phosphate was 
shown to lead to an accumulation of sedoheptulose 
7-phosphate. The present results with Krebs ascites 
cells also point to the importance of such factors in 
the accumulation of sedoheptulose 7-phosphate. In 
intact ascites cells where the full complement of co- 
enzymes and cofactors is available, glyceraldehyde 
3-phosphate may be metabolised to yield 1: 3 diphos 
phoglycerate, or it may be converted to cr-glycero- 
phosphate or fructose 1 : 6 diphosphate. The results 
reported here point to a close integration of the pen- 
tose phosphate pathway and the glycolytic route at 
the level of triose phosphate. 
Another important control mechanism relating the 
two pathways of glucose metabolism may be found in 
the competitive inhibition of phosphoglucose iso- 
merase by sedoheptulose 7-phosphate. The reported 
Ki for this enzyme is 8.6 X 10-6 M [ 121, well below 
the concentration found in ascites tumour cells, which 
is 0.2 mM; the authors state that this inhibition may 
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well be modified by the concentration of intracellular 
glutathione and cysteine. 
(31 I.A.Rose, in: Control of Energy Metabolism, p. 177. 
[4] R.Wu, Biochem. Biophys. Res. Commun. 18 (1965) 
402. 
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